000 01455 a2200457 4500
005 20250517225645.0
264 0 _c20190226
008 201902s 0 0 eng d
022 _a1868-8551
024 7 _a10.14573/altex.1805301
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrimm, Fabian A
245 0 0 _aA human population-based organotypic in vitro model for cardiotoxicity screening.
_h[electronic resource]
260 _bALTEX
_c2018
300 _a441-452 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCardiotoxicity
_xgenetics
650 0 4 _aCardiovascular Agents
_xpharmacology
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHealthy Volunteers
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInduced Pluripotent Stem Cells
_xcytology
650 0 4 _aMale
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aPhenotype
650 0 4 _aReproducibility of Results
700 1 _aBlanchette, Alexander
700 1 _aHouse, John S
700 1 _aFerguson, Kyle
700 1 _aHsieh, Nan-Hung
700 1 _aDalaijamts, Chimeddulam
700 1 _aWright, Alec A
700 1 _aAnson, Blake
700 1 _aWright, Fred A
700 1 _aChiu, Weihsueh A
700 1 _aRusyn, Ivan
773 0 _tALTEX
_gvol. 35
_gno. 4
_gp. 441-452
856 4 0 _uhttps://doi.org/10.14573/altex.1805301
_zAvailable from publisher's website
999 _c28624974
_d28624974